Work absenteeism, disability, and lost wages among patients with acute myeloid leukemia and their caregivers : a cohort study using US administrative claims and productivity data
OBJECTIVE: We describe the impact of acute myeloid leukemia (AML) diagnosis on workplace absenteeism and disability days among patients and their caregivers.
METHODS: This retrospective study included adults with newly diagnosed AML (2009-2019) and adult caregivers of patients with newly diagnosed AML, identified from the US Merative™ MarketScan® Commercial Database. The Merative MarketScan Health and Productivity Management Database provided linked patient-level records of workplace absence and short-term (STD) and long-term disability (LTD) data. Endpoints included workplace absence, STD and LTD for patients and caregivers during 12 months pre-AML (baseline) and ≤3 years' follow-up, and corresponding cost of work loss.
RESULTS: Patient workplace absence decreased in the months post-AML diagnosis, but the number of STD and LTD leave days claimed increased significantly by sixfold and fourfold, respectively. The proportion of patients making STD leave claims increased within 4-5 months of diagnosis, while the proportion making LTD leave claims increased significantly starting from month 5. Caregiver workplace absence peaked in the first 2 months post-diagnosis and remained elevated versus baseline throughout the study.
CONCLUSION: AML diagnosis leads to workplace absenteeism and increased economic burden for patients with AML and their caregivers.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
Expert review of pharmacoeconomics & outcomes research - 24(2024), 4 vom: 13. Apr., Seite 521-532 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pandya, Bhavik J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Absenteeism |
|---|
| Anmerkungen: |
Date Completed 10.04.2024 Date Revised 10.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/14737167.2024.2311305 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367846217 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367846217 | ||
| 003 | DE-627 | ||
| 005 | 20240410232443.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240131s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14737167.2024.2311305 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1371.xml |
| 035 | |a (DE-627)NLM367846217 | ||
| 035 | |a (NLM)38294308 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pandya, Bhavik J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Work absenteeism, disability, and lost wages among patients with acute myeloid leukemia and their caregivers |b a cohort study using US administrative claims and productivity data |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.04.2024 | ||
| 500 | |a Date Revised 10.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a OBJECTIVE: We describe the impact of acute myeloid leukemia (AML) diagnosis on workplace absenteeism and disability days among patients and their caregivers | ||
| 520 | |a METHODS: This retrospective study included adults with newly diagnosed AML (2009-2019) and adult caregivers of patients with newly diagnosed AML, identified from the US Merative™ MarketScan® Commercial Database. The Merative MarketScan Health and Productivity Management Database provided linked patient-level records of workplace absence and short-term (STD) and long-term disability (LTD) data. Endpoints included workplace absence, STD and LTD for patients and caregivers during 12 months pre-AML (baseline) and ≤3 years' follow-up, and corresponding cost of work loss | ||
| 520 | |a RESULTS: Patient workplace absence decreased in the months post-AML diagnosis, but the number of STD and LTD leave days claimed increased significantly by sixfold and fourfold, respectively. The proportion of patients making STD leave claims increased within 4-5 months of diagnosis, while the proportion making LTD leave claims increased significantly starting from month 5. Caregiver workplace absence peaked in the first 2 months post-diagnosis and remained elevated versus baseline throughout the study | ||
| 520 | |a CONCLUSION: AML diagnosis leads to workplace absenteeism and increased economic burden for patients with AML and their caregivers | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Absenteeism | |
| 650 | 4 | |a acute myeloid leukemia | |
| 650 | 4 | |a caregivers | |
| 650 | 4 | |a disability | |
| 650 | 4 | |a economic burden | |
| 650 | 4 | |a wage loss | |
| 700 | 1 | |a Young, Christopher |e verfasserin |4 aut | |
| 700 | 1 | |a Packnett, Elizabeth R |e verfasserin |4 aut | |
| 700 | 1 | |a Xie, Bin |e verfasserin |4 aut | |
| 700 | 1 | |a Lillehaugen, Timothy |e verfasserin |4 aut | |
| 700 | 1 | |a Block, Alana |e verfasserin |4 aut | |
| 700 | 1 | |a Bernacki, Katarzyna |e verfasserin |4 aut | |
| 700 | 1 | |a Touya, Maelys |e verfasserin |4 aut | |
| 700 | 1 | |a LeBlanc, Thomas W |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert review of pharmacoeconomics & outcomes research |d 2001 |g 24(2024), 4 vom: 13. Apr., Seite 521-532 |w (DE-627)NLM187860815 |x 1744-8379 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2024 |g number:4 |g day:13 |g month:04 |g pages:521-532 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/14737167.2024.2311305 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2024 |e 4 |b 13 |c 04 |h 521-532 | ||